April 1, 2012
CHICAGO — A genetic mutation in MEK1 does not prevent response to BRAF inhibitors in patients undergoing treatment for BRAF-mutated melanomas,...
April 1, 2012
CHICAGO — Leaders from the American Association for Cancer Research, which today opened its AACR Annual Meeting 2012 here, declared that the...
April 1, 2012
CHICAGO — Local breast radiation therapy may not be necessary for women with the luminal A subtype of breast cancer, particularly those aged...
April 1, 2012
CHICAGO — In a landmark study, researchers have linked the long-term use of estrogen plus progesterone and estrogen-only hormone therapy with a...
April 1, 2012
CHICAGO — College-age African-American women have a more difficult time clearing human papillomavirus infection and are more likely to have an...
April 1, 2012
CHICAGO — The incidence of breast cancer-associated metastasis was increased in animal models of the chronic inflammatory condition arthritis,...
April 1, 2012
CHICAGO — Researchers have identified specific proteins involved in translation that when overexpressed or activated are associated with a...
March 31, 2012
CHICAGO — Hypoxia, or a lack of oxygen, in prostate cancer tumors was associated with early biochemical relapse and local recurrence after...
March 31, 2012
CHICAGO — The epidermal growth factor receptor mutations that occur in glioblastoma differ from those that occur in lung cancers — a...
March 31, 2012
CHICAGO — Use of a novel, noninvasive imaging tool allowed researchers to measure free prostate-specific antigen in prostate cancer models and...
March 31, 2012
CHICAGO — Selumetinib, a small-molecule MEK inhibitor, demonstrated the ability to control low-grade serous ovarian or peritoneal cancer,...
March 31, 2012
CHICAGO — The antiangiogenic drug pazopanib has demonstrated clinically meaningful activity in patients with refractory urothelial cancer,...
March 31, 2012
CHICAGO — Higher oral doses of plain vitamin D raised levels of calcitriol in prostate tissue. Higher prostate levels of calcitriol, a hormone...
March 31, 2012
CHICAGO — Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen...
March 31, 2012
CHICAGO — A combination of targeted therapies may be effective against relapsed or recurrent Ewing’s sarcoma or desmoplastic...
March 31, 2012
CHICAGO — The use of metformin in men with prostate cancer before prostatectomy helped to reduce certain metabolic parameters and slow the...
March 31, 2012
PHILADELPHIA — Metformin, a widely used, well-tolerated drug prescribed for patients with diabetes, may protect against liver cancer, according...
March 31, 2012
PHILADELPHIA — New findings published in Cancer Prevention Research, a journal of the American Association for Cancer Research, suggest that...
March 31, 2012
PHILADELPHIA — Patients with diabetes and pancreatic cancer who are prescribed metformin may have improved survival compared with those not...
March 31, 2012
PHILADELPHIA — The combination of metformin, a commonly prescribed antidiabetic drug, and vascular endothelial growth factor-A inhibitors...